R S Medansky|R M Handler|D L Medansky - JoVE Visualize

Showing results (1-10 of 11) with videos related to

Pageof 2

Sort By:

International Journal of Dermatology|November 1, 1979

Treatment of psoriasis with topical nitrogen mustardR M Handler, R S Medansky

Journal of the American Academy of Dermatology|August 1, 1981

Dermatopsychosomatics: classification, physiology, and therapeutic approachesR S Medansky, R M Handler

Cutis|January 1, 1978

Analysis of a new corticosteroid aerosol in treatment of contact dermatitisR S Medansky, R M Handler

International Journal of Dermatology|January 1, 1979

A trial with fluocinonide in recalcitrant dermatosesR S Medansky, R M Handler, W Cook, et al.

Clinical Therapeutics|July 1, 1997

Mometasone furoate 0.1%-salicylic acid 5% ointment twice daily versus fluocinonide 0.05% ointment twice daily in the management of patients with psoriasisR S Medansky, C A Cuffie, D J Tanner

Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 1, 1997

Effect of locus of control and consideration of future consequences on time tradeoff utilities for current healthR M Handler, L M Hynes, R F Nease

Dermatologica|January 1, 1991

Intermittent corticosteroid maintenance treatment of psoriasis: a double-blind multicenter trial of augmented betamethasone dipropionate ointment in a pulse dose treatment regimenH I Katz, S E Prawer, R S Medansky, et al.

Cutis|August 1, 1984

SCH 370 (clotrimazole-betamethasone dipropionate) cream in patients with tinea cruris or tinea corporisH I Katz, J Bard, G W Cole, et al.

Journal of the American Academy of Dermatology|March 1, 1991

A double-blind, vehicle-controlled study of clobetasol propionate 0.05% (Temovate) scalp application in the treatment of moderate to severe scalp psoriasisE A Olsen, D L Cram, C N Ellis, et al.

Cutis|November 1, 1988

Mometasone furoate ointment and cream 0.1 percent in treatment of psoriasis: comparison with ointment and cream formulations of fluocinolone acetonide 0.025 percent and triamcinolone acetonide 0.1 percentR S Medansky, R Bressinck, G W Cole, et al.

Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:

Pageof 2

International Journal of Dermatology|November 1, 1979

Treatment of psoriasis with topical nitrogen mustardR M Handler, R S Medansky

Journal of the American Academy of Dermatology|August 1, 1981

Dermatopsychosomatics: classification, physiology, and therapeutic approachesR S Medansky, R M Handler

Cutis|January 1, 1978

Analysis of a new corticosteroid aerosol in treatment of contact dermatitisR S Medansky, R M Handler

International Journal of Dermatology|January 1, 1979

A trial with fluocinonide in recalcitrant dermatosesR S Medansky, R M Handler, W Cook, et al.

Clinical Therapeutics|July 1, 1997

Mometasone furoate 0.1%-salicylic acid 5% ointment twice daily versus fluocinonide 0.05% ointment twice daily in the management of patients with psoriasisR S Medansky, C A Cuffie, D J Tanner

Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 1, 1997

Effect of locus of control and consideration of future consequences on time tradeoff utilities for current healthR M Handler, L M Hynes, R F Nease

Dermatologica|January 1, 1991

Intermittent corticosteroid maintenance treatment of psoriasis: a double-blind multicenter trial of augmented betamethasone dipropionate ointment in a pulse dose treatment regimenH I Katz, S E Prawer, R S Medansky, et al.

Cutis|August 1, 1984

SCH 370 (clotrimazole-betamethasone dipropionate) cream in patients with tinea cruris or tinea corporisH I Katz, J Bard, G W Cole, et al.

Journal of the American Academy of Dermatology|March 1, 1991

A double-blind, vehicle-controlled study of clobetasol propionate 0.05% (Temovate) scalp application in the treatment of moderate to severe scalp psoriasisE A Olsen, D L Cram, C N Ellis, et al.

Cutis|November 1, 1988

Mometasone furoate ointment and cream 0.1 percent in treatment of psoriasis: comparison with ointment and cream formulations of fluocinolone acetonide 0.025 percent and triamcinolone acetonide 0.1 percentR S Medansky, R Bressinck, G W Cole, et al.

Pageof 2